NCT00534846View on ClinicalTrials.gov

The Effect of Toremifene Treatment to the Magnetic Resonance Imaging (MRI) Findings in Premenstrual Mastalgia

PHASE3CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

February 28, 2009

Conditions
Breast Pain
Interventions
DRUG

toremifene

The medication is given in tablet form, and the participants are instructed to take one tablet daily from cycle day 15 until the next menstruation. The active (toremifene 20 mg) and control (placebo) tablets were identical in appearance.

DRUG

placebo

tablet equal to toremifene, one tablet daily from cycle day 15 to menstruation during three cycles

Trial Locations (1)

28500

Satakunta Central hospital, department of gynaecology and obstetrics, Pori

All Listed Sponsors
collaborator

Tampere University

OTHER

lead

Satakunta Central Hospital

OTHER

NCT00534846 - The Effect of Toremifene Treatment to the Magnetic Resonance Imaging (MRI) Findings in Premenstrual Mastalgia | Biotech Hunter | Biotech Hunter